Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

2.

Truncations of titin causing dilated cardiomyopathy.

Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE.

N Engl J Med. 2012 Feb 16;366(7):619-28. doi: 10.1056/NEJMoa1110186.

3.

Adolescents with implantable cardioverter defibrillators: a patient and parent perspective.

Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE.

Pacing Clin Electrophysiol. 2012 Jan;35(1):62-72. doi: 10.1111/j.1540-8159.2011.03229.x. Epub 2011 Oct 3.

PMID:
21967596
4.

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A, Shimizu W, Sumitomo N, Fish FA, Bhuiyan ZA, Willems AR, van der Veen MJ, Watanabe H, Laborderie J, Haïssaguerre M, Knollmann BC, Wilde AA.

J Am Coll Cardiol. 2011 May 31;57(22):2244-54. doi: 10.1016/j.jacc.2011.01.026.

5.

Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies.

Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, Tarassenko L, Mant D.

Lancet. 2011 Mar 19;377(9770):1011-8. doi: 10.1016/S0140-6736(10)62226-X. Review.

6.

Mitochondrial uncoupling downregulates calsequestrin expression and reduces SR Ca2+ stores in cardiomyocytes.

Hänninen SL, Ronkainen JJ, Leskinen H, Tavi P.

Cardiovasc Res. 2010 Oct 1;88(1):75-82. doi: 10.1093/cvr/cvq180. Epub 2010 Jun 4.

PMID:
20525644
7.

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC.

Nat Med. 2009 Apr;15(4):380-3. doi: 10.1038/nm.1942. Epub 2009 Mar 29.

8.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
9.

Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.

Sumitomo N, Sakurada H, Taniguchi K, Matsumura M, Abe O, Miyashita M, Kanamaru H, Karasawa K, Ayusawa M, Fukamizu S, Nagaoka I, Horie M, Harada K, Hiraoka M.

Circ J. 2007 Oct;71(10):1606-9.

10.

A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.

Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ.

Heart Rhythm. 2007 Jun;4(6):733-9. Epub 2007 Mar 3.

11.

Pacemakers and implantable cardioverter-defibrillators in pediatric patients.

Silka MJ, Bar-Cohen Y.

Heart Rhythm. 2006 Nov;3(11):1360-6. Epub 2006 Feb 28. Review.

PMID:
17074646
12.

Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.

Tester DJ, Arya P, Will M, Haglund CM, Farley AL, Makielski JC, Ackerman MJ.

Heart Rhythm. 2006 Jul;3(7):800-5. Epub 2006 Mar 28.

PMID:
16818210
13.

A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.

Hsueh CH, Weng YC, Chen CY, Lin TK, Lin YH, Lai LP, Lin JL.

Int J Cardiol. 2006 Apr 4;108(2):276-8.

PMID:
16517285
14.

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.

J Med Genet. 2005 Nov;42(11):863-70.

15.

Implantable cardioverter-defibrillators, induced anxiety, and quality of life.

Sola CL, Bostwick JM.

Mayo Clin Proc. 2005 Feb;80(2):232-7. Review.

PMID:
15704778
16.
17.

Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy.

Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, Craigen WJ, Wu J, El Said H, Bezold LI, Clunie S, Fernbach S, Bowles NE, Towbin JA.

Circulation. 2003 Nov 25;108(21):2672-8. Epub 2003 Nov 17.

18.

Electrocardiographic findings in 67,375 asymptomatic subjects. X. Normal values.

HISS RG, LAMB LE, ALLEN MF.

Am J Cardiol. 1960 Jul;6:200-31. No abstract available.

PMID:
13855921
19.

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M.

Am J Hum Genet. 2001 Dec;69(6):1378-84. Epub 2001 Oct 25.

20.

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA.

Circulation. 2001 Jan 16;103(2):196-200.

Supplemental Content

Support Center